Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy by Hoyoung M. Maeng, Brittni N. Moore, Hadi Bagheri, Seth M. Steinberg, Jon Inglefield, Kim Dunham, Wei-Zen Wei, John C. Morris, Masaki Terabe, Lee C. England, Brenda Roberson, Douglas Rosing, Vandana Sachdev, Svetlana D. Pack, Markku M. Miettinen, Frederic G. Barr, Louis M. Weiner, Sandhya Panch, David F. Stroncek, Lauren V. Wood, Jay A. Berzofsky

Get full text